Insulin Sensitivity, Clearance and Release in Kininogen‐Deficient Rats

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Experimental Physiology

• Publication date

  1999-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1469-445X.1999.01812.xPMID 10362853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.

  1998cited by this paper
• Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts.

  1998cited by this paper
• Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

  1998cited by this paper
• Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance.

  1998cited by this paper
• Effect of Captopril, Losartan, and Bradykinin on Early Steps of Insulin Action

  1997cited by this paper
• The effect of bradykinin on secretion of insulin, glucagon, and somatostatin from the perfused rat pancreas.

  1997cited by this paper
• The brown Norway rats and the kinin system.

  1996cited by this paper
• Skeletal Muscle Kallikrein: Potential Role in Metabolic Regulation

  1996cited by this paper
• Kininogen changes in human plasma following a test meal or insulin administration.

  1996cited by this paper
• Kinin B1 receptors: a review.

  1995cited by this paper
• Stimulatory effect of bradykinin on insulin release from the perfused rat pancreas.

  1995cited by this paper
• Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia.

  1995influential reference
• How to measure insulin clearance.

  1994cited by this paper
• Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.

  1994cited by this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• Angiotensin‐Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

  1992cited by this paper
• Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies

  1991cited by this paper
• Metabolic effects of ACE inhibitors.

  1991cited by this paper
• Metabolic Effects of Kinins: Historical and Recent Developments

  1990cited by this paper
• Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.

  1985cited by this paper
• In vivo insulin sensitivity in the rat determined by euglycemic clamp.

  1983cited by this paper
• Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins.

  1982cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper
• [Modification of the Hales-Randle procedure for the radioimmunoassay of insulin].

  1969cited by this paper

• Characterization of the Skeletal Muscle Proteome in Undernourished Old Rats

  2022cites this paper
• Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions

  2020cites this paper
• The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.

  2017cites this paper
• Screening for potential serum‐based proteomic biomarkers for human type 2 diabetes mellitus using MALDI‐TOF MS

  2017cites this paper
• The Angiotensin-Converting-Enzyme-Induced Angioedema.

  2017cites this paper
• Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck

  2016cites this paper
• Evidenz und Evidenzlücken für medikamentös zu behandelnde, nicht-tumoröse Erkrankungen im Gebiet der HNO-Heilkunde

  2016cites this paper
• Effects of different milk proteins on the metabolic response in healthy and prediabetic volunteers

  2015cites this paper
• Rôle du système kallicréine-kinine(s) dans les complications du diabète

  2015cites this paper
• Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man.

  2014cites this paper
• Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus

  2014cites this paper
• Mechanisms for the sustained effects of prior exercise on AS160 phosphorylation and insulin-stimulated glucose transport in rodent skeletal muscle

  2012cites this paper
• Postexercise skeletal muscle glucose transport is normal in kininogen-deficient rats.

  2011cites this paper
• Biochemical characterization of a cysteine proteinase from Bauhinia forficata leaves and its kininogenase activity

  2011cites this paper
• IUGR in the Absence of Postnatal “Catch-Up” Growth Leads to Improved Whole Body Insulin Sensitivity in Rat Offspring

  2011cites this paper
• The B2 receptor of bradykinin is not essential for the post-exercise increase in glucose uptake by insulin-stimulated mouse skeletal muscle.

  2011cites this paper
• Concordance of two multiple analytical approaches demonstrate that interaction between BMI and ADIPOQ haplotypes is a determinant of LDL cholesterol in a general French population

  2010cites this paper
• The renin angiotensin system and the metabolic syndrome.

  2010cites this paper
• The B 2 receptor of bradykinin is not essential for the post-exercise increase in glucose uptake by insulin-stimulated mouse skeletal muscle

  2010cites this paper
• Cardioprotective properties of bradykinin: role of the B2 receptor

  2010cites this paper
• Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice

  2010cites this paper
• Insulin Sensitivity is Enhanced by CGMP-mediated MAPK Inhibition in Rat Adipocytes

  2010cites this paper
• Review: Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis

  2008cites this paper
• Genetically altered animals in the study of the metabolic functions of peptide hormone systems

  2008cites this paper
• The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.

  2008cites this paper
• Nonallergic angioedema: role of bradykinin

  2007cites this paper
• Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.

  2006cites this paper
• EIF4A2 is a positional candidate gene at the 3q27 locus linked to type 2 diabetes in French families.

  2006cites this paper
• Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function

  2006cites this paper
• Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy.

  2005cites this paper
• Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.

  2005cites this paper
• Does insulin release kinins in rats?

  2005cites this paper
• Effect of imidapril, an angiotensin-converting enzyme inhibitor, on fructose-induced insulin resistance in rats.

  2004cites this paper
• The kallikrein‐kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity

  2004influential citation
• Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.

  2004cites this paper
• Gene Therapy With Human Tissue Kallikrein Reduces Hypertension and Hyperinsulinemia in Fructose-Induced Hypertensive Rats

  2003cites this paper
• Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats.

  2003cites this paper
• The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

  2003cites this paper
• Diet-induced obesity in the rat: a model for gestational diabetes mellitus.

  2003cites this paper
• Non-peptide antagonists and agonists of the bradykinin B(2) receptor.

  2002cites this paper
• Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats

  2002cites this paper
• Kinins and kinin receptors in the pathogenesis of heart failure

  2002cites this paper
• Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin

  2002cites this paper
• Acute effect of the dual angiotensin‐converting enzyme and neutral endopeptidase 24‐11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat

  2001cites this paper
• Kinin receptors and their antagonists as novel therapeutic agents.

  2001cites this paper
• Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats

  2001cites this paper
• The effect of bradykinin on the oxidative state of rats with acute hyperglycaemia.

  2001cites this paper
• Role of the B2 Receptor of Bradykinin in Insulin Sensitivity

  2001cites this paper
• Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways.

  2000cites this paper
• Bradykinin B2 receptor as a potential therapeutic target.

  2000cites this paper